Protocol Ledger

NCT06374797 · Phase II · TERMINATED

A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"

Interventional Phase II clinical trial protocol NCT06374797 sponsored by CalciMedica in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-07-01 Enrollment: 122 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06374797
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)122 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06374797
Protocol FieldVerified Registry Value
NCT IdentifierNCT06374797
Consolidated Lead SponsorCalciMedica
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment122 participants (ACTUAL)
Registered Start Date2024-07-01
WhyStopped ClassificationUnspecified

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI